<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2008-12-1-53-57</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1014</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. EXPERIMENTAL INVESTIGATION</subject></subj-group></article-categories><title-group><article-title>ОБРАТИМОСТЬ  СТРУКТУРНЫХ  ИЗМЕНЕНИЙ  МОЗГОВОГО  ВЕЩЕСТВА  ПОЧКИ  КРЫС,  ВЫЗВАННЫХ  СУБХРОНИЧЕСКИМ  ПРИЕМОМ  ЭТИЛЕНГЛИКОЛЯ</article-title><trans-title-group xml:lang="en"><trans-title>REVERSIBILITY OF STRUCTURAL CHANGES OF THE  RATS  KIDNEY  MEDULLA CAUSED  BY SUBCHRONIC  INTAKE OF ETHYLENE GLYCOL</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Талалаев</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Talalaev</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедры гистологии, патологической анатомии и фармакологии Алтайского государственного медицинского университета;</p><p>отдел биотехнологии Биолого-почвенного института ДВО  РАН</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лепилов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lepilov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедры гистологии, патологической анатомии и фармакологии Алтайского государственного медицинского университета;</p><p>отдел биотехнологии Биолого-почвенного института ДВО  РАН</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Булгаков</surname><given-names>В. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Bulgakov</surname><given-names>V. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедры гистологии, патологической анатомии и фармакологии Алтайского государственного медицинского университета;</p><p>отдел биотехнологии Биолого-почвенного института ДВО  РАН</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зверев</surname><given-names>Я. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Zverev</surname><given-names>Ya. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедры гистологии, патологической анатомии и фармакологии Алтайского государственного медицинского университета;</p><p>отдел биотехнологии Биолого-почвенного института ДВО  РАН</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лампатов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lampatov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедры гистологии, патологической анатомии и фармакологии Алтайского государственного медицинского университета;</p><p>отдел биотехнологии Биолого-почвенного института ДВО  РАН</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лель</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lel</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедры гистологии, патологической анатомии и фармакологии Алтайского государственного медицинского университета;</p><p>отдел биотехнологии Биолого-почвенного института ДВО  РАН</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мотин</surname><given-names>Ю. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Motin</surname><given-names>Yu. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедры гистологии, патологической анатомии и фармакологии Алтайского государственного медицинского университета;</p><p>отдел биотехнологии Биолого-почвенного института ДВО  РАН</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Алтайский государственный медицинский университет;&#13;
Биолого-почвенный институт ДВО  РАН</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>10</day><month>01</month><year>2008</year></pub-date><volume>12</volume><issue>1</issue><fpage>53</fpage><lpage>57</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Талалаев С.В., Лепилов А.В., Булгаков В.П., Зверев Я.Ф., Лампатов В.В., Лель Н.В., Мотин Ю.Г., 2008</copyright-statement><copyright-year>2008</copyright-year><copyright-holder xml:lang="ru">Талалаев С.В., Лепилов А.В., Булгаков В.П., Зверев Я.Ф., Лампатов В.В., Лель Н.В., Мотин Ю.Г.</copyright-holder><copyright-holder xml:lang="en">Talalaev S.V., Lepilov A.V., Bulgakov V.P., Zverev Y.F., Lampatov V.V., Lel N.V., Motin Y.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1014">https://journal.nephrolog.ru/jour/article/view/1014</self-uri><abstract><p>ЦЕЛЬЮ ИССЛЕДОВАНИЯ явилось комплексное морфофункциональное изучение воздействия этиленгликоля на мозговое вещество почки, оценка обратимости вызываемых изменений и особенностей распределения кальциевых депозитов в условиях экспериментального  нефролитиаза. МАТЕРИАЛ И МЕТОДЫ. Эксперимент был  поставлен  на 20 самцах крыс Wistar массой 200-250 г. Все животные были разделены на 4 группы,  по 5 крыс в каждой. Крысы 1-й  группы получали в качестве питья чистую воду, 2-й группы  -  1%  раствор  этиленгликоля  в  течение  21 сут., что индуцировало  развитие экспериментального нефролитиаза. Животным 3-й группы, предварительно получавшим этиленгликоль на протяжении 21 суток, по окончании этого периода в течение 3-х недель через зонд вводили в желудок в 2%-й крахмальной взвеси препарат из культуры тканей Марены сердцелистной (Rubia Cordifolia) в дозе 75 м г/кг. Животные 4-й группы одновременно получали препарат Марены сердцелистной и 1%-й раствор этиленгликоля в течение 21 дня. РЕЗУЛЬТАТЫ. Показана обратимость морфологической перестройки почки, вызванной субхроническим воздействием этиленгликоля, и протективное действие приема препарата из культуры тканей Марены сердцелистной. ЗАКЛЮЧЕНИЕ. Введение препарата из культуры тканей Марены сердцелистной приводит к обратимости морфологических изменений мозгового вещества почки, вызванных субхроническим приемом этиленгликоля.</p></abstract><trans-abstract xml:lang="en"><p>THE AIM of the investigation was a complex morpho-functional study of the action of ethylene glycol on the kidney medullary substance, estimation of reversibility of the resulting changes and specificities of the distribution of calcium deposits under conditions of experimental nephrolithiasis. MATERIAL AND METHODS. The experiment was carried out in 20 male Wistar rats, body mass 200-250 g. The animals were divided into 4 groups, 5 rats in each. Rats of the 1st group were given pure water, 2nd group  -  1%  of ethylene glycol during 21 days that induced the development of experimental nephrolithiasis. The 3rd group animals, previously given ethylene glycol during 21 days, after this period received 2% starch suspension with a preparation from tissue culture of Rubia Cordifolia in dosage 75 mg/kg during 3 weeks. The 4th group animals simultaneously received the preparation from Rubia Cordifolia and a 1% solution of ethylene glycol during 21 days. RESULTS. The work has shown reversibility of the morphological alterations in the kidney caused by subchronic effects of ethylene glycol, and protective action of the preparation from tissue culture of Rubia Cordifolia. CONCLUSION. Administration of the preparation from tissue culture of Rubia Cordifolia results in reversible morphological alterations to the medullary substance of the kidney caused by subchronic intake of ethylene glycol.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>почка</kwd><kwd>соли кальция</kwd><kwd>камнеобразование</kwd></kwd-group><kwd-group xml:lang="en"><kwd>kidney</kwd><kwd>calcium salts</kwd><kwd>nephrolithiasis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Тиктинский ОЛ, Александров ВП. Мочекаменная болезнь. СПб., 2000; 3-12</mixed-citation><mixed-citation xml:lang="en">Тиктинский ОЛ, Александров ВП. Мочекаменная болезнь. СПб., 2000; 3-12</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Coe FL, Evan A, Wocester E. Kidney stone disease. J Clin Invest 2005; 115(10): 2598-2608</mixed-citation><mixed-citation xml:lang="en">Coe FL, Evan A, Wocester E. Kidney stone disease. J Clin Invest 2005; 115(10): 2598-2608</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Daudon M. Epidemiology of nephrolithiasis in France. Ann Urol (Paris) 2005; 39(6): 209-231</mixed-citation><mixed-citation xml:lang="en">Daudon M. Epidemiology of nephrolithiasis in France. Ann Urol (Paris) 2005; 39(6): 209-231</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Matlaga BR, Coe FL, Evan AP, Lingeman JE. The role of Randall’s plaques in the pathogenesis of calcium stones. J Urol 2007; 177: 31-38</mixed-citation><mixed-citation xml:lang="en">Matlaga BR, Coe FL, Evan AP, Lingeman JE. The role of Randall’s plaques in the pathogenesis of calcium stones. J Urol 2007; 177: 31-38</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cruzan G, Corley RA, Hard DC et al. Subchronic toxicity of ethylene glycol in Wistar and F-344 rats related to metabolism and clearance of metabolites. Toxicol Sci 2004; 81 (2): 502-511</mixed-citation><mixed-citation xml:lang="en">Cruzan G, Corley RA, Hard DC et al. Subchronic toxicity of ethylene glycol in Wistar and F-344 rats related to metabolism and clearance of metabolites. Toxicol Sci 2004; 81 (2): 502-511</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Khan SR, Hacklett RL. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature. Scan Electron Microsc 1985; Pt.2: 759-774</mixed-citation><mixed-citation xml:lang="en">Khan SR, Hacklett RL. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature. Scan Electron Microsc 1985; Pt.2: 759-774</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Khan SR. Animal models of kidney stone formation: an analysis. World J Urol 1997; 15(4): 236-243</mixed-citation><mixed-citation xml:lang="en">Khan SR. Animal models of kidney stone formation: an analysis. World J Urol 1997; 15(4): 236-243</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Yamaguchi S, Wiessner JH, Hasegawa AT et al. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions. Int J Urol 2005; 12 (3): 290-298</mixed-citation><mixed-citation xml:lang="en">Yamaguchi S, Wiessner JH, Hasegawa AT et al. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions. Int J Urol 2005; 12 (3): 290-298</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with image. J Biophotonics International 2004; 11(7): 36-42</mixed-citation><mixed-citation xml:lang="en">Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with image. J Biophotonics International 2004; 11(7): 36-42</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar S, Sigmon D, Miller T et al. A new model of nephrolithiasis involving tubular dysfunction / injury. J Urol 1991; 146(5): 1384-1389</mixed-citation><mixed-citation xml:lang="en">Kumar S, Sigmon D, Miller T et al. A new model of nephrolithiasis involving tubular dysfunction / injury. J Urol 1991; 146(5): 1384-1389</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Khan SR. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones. Scanning Microsc 1995; 9(1): 89-100</mixed-citation><mixed-citation xml:lang="en">Khan SR. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones. Scanning Microsc 1995; 9(1): 89-100</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bushinsky DA. Nephrolithiasis: site of the initial solid phase. J Clin Invest 2003; 111(5): 602-605</mixed-citation><mixed-citation xml:lang="en">Bushinsky DA. Nephrolithiasis: site of the initial solid phase. J Clin Invest 2003; 111(5): 602-605</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
